| Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry S Lehmann, A Ravn, L Carlsson, P Antunovic, S Deneberg, L Möllgård, ... Leukemia 25 (7), 1128-1134, 2011 | 359 | 2011 |
| Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis--a randomized … I Hafström, M Rohani, S Deneberg, M Wörnert, T Jogestrand, J Frostegård The Journal of rheumatology 34 (9), 1810-1816, 2007 | 170 | 2007 |
| Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia S Deneberg, M Grövdal, M Karimi, M Jansson, H Nahi, A Corbacioglu, ... Leukemia 24 (5), 932-941, 2010 | 147 | 2010 |
| Complete long‐term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer J Lehmann, L Franzaring, J Thüroff, S Wellek, M Stöckle BJU international 97 (1), 42-47, 2006 | 126 | 2006 |
| Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant … Y Qu, A Lennartsson, VI Gaidzik, S Deneberg, M Karimi, S Bengtzén, ... Epigenetics 9 (8), 1108-1119, 2014 | 116 | 2014 |
| An open-label phase I dose-finding study of APR-246 in hematological malignancies S Deneberg, H Cherif, V Lazarevic, PO Andersson, M Von Euler, ... Blood cancer journal 6 (7), e447-e447, 2016 | 97 | 2016 |
| Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks S Deneberg, P Guardiola, A Lennartsson, Y Qu, V Gaidzik, O Blanchet, ... Blood, The Journal of the American Society of Hematology 118 (20), 5573-5582, 2011 | 93 | 2011 |
| Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter … P Montesinos, GJ Roboz, CE Bulabois, M Subklewe, U Platzbecker, ... Leukemia 35 (1), 62-74, 2021 | 77 | 2021 |
| APR‐246 exhibits anti‐leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cells D Ali, K Jönsson‐Videsäter, S Deneberg, S Bengtzén, H Nahi, C Paul, ... European journal of haematology 86 (3), 206-215, 2011 | 77 | 2011 |
| The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting G Juliusson, M Jädersten, S Deneberg, S Lehmann, L Möllgård, ... Blood advances 4 (6), 1094-1101, 2020 | 69 | 2020 |
| microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemia S Deneberg, M Kanduri, D Ali, S Bengtzen, M Karimi, Y Qu, E Kimby, ... Epigenetics 9 (6), 910-917, 2014 | 58 | 2014 |
| Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997–2013 S Lehmann, S Deneberg, P Antunovic, Å Rangert-Derolf, H Garelius, ... Leukemia 31 (6), 1457-1459, 2017 | 55 | 2017 |
| Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period G Juliusson, O Hagberg, VL Lazarevic, E Ölander, P Antunovic, ... Blood, The Journal of the American Society of Hematology 134 (18), 1558-1561, 2019 | 50 | 2019 |
| The FLT3 inhibitor PKC412 in combination with cytostatic drugs in vitro in acute myeloid leukemia L Möllgård, S Deneberg, H Nahi, S Bengtzen, K Jonsson-Videsäter, ... Cancer chemotherapy and pharmacology 62, 439-448, 2008 | 42 | 2008 |
| Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR—final report from AFTER-SKI J Richter, A Lübking, S Söderlund, K Lotfi, B Markevärn, A Själander, ... Leukemia 35 (8), 2416-2418, 2021 | 21 | 2021 |
| AML displays increased CTCF occupancy associated with aberrant gene expression and transcription factor binding H Mujahed, S Miliara, A Neddermeyer, S Bengtzén, C Nilsson, ... Blood, The Journal of the American Society of Hematology 136 (3), 339-352, 2020 | 21 | 2020 |
| Single nucleotide polymorphism genomic arrays analysis of t (8; 21) acute myeloid leukemia cells T Akagi, LY Shih, S Ogawa, J Gerss, SR Moore, R Schreck, N Kawamata, ... haematologica 94 (9), 1301, 2009 | 20 | 2009 |
| A risk score based on real-world data to predict early death in acute promyelocytic leukemia A Österroos, T Maia, A Eriksson, M Jädersten, V Lazarevic, L Wennström, ... Haematologica 107 (7), 1528, 2022 | 19 | 2022 |
| Acute myeloid leukemia in very old patients VL Lazarevic, A Bredberg, F Lorenz, E Öhlander, P Antunovic, ... Haematologica 103 (12), e578, 2018 | 19 | 2018 |
| Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications C Nilsson, F Linde, E Hulegårdh, H Garelius, V Lazarevic, P Antunovic, ... Haematologica 108 (4), 1015, 2023 | 17 | 2023 |
